Skip to main content

Animations

MJFF Publications

1461 - 1470 of 6324 Results
Title
Year
  • Year
  • 2017
  • 2013
  • 2008
  • 2008
  • 2017
  • 2011
  • 2012
  • 2015
  • 2012
  • 2012
  • Summary Details
    OPEN
    Title: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.421
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2013.10.159
    Citation Count: 82
  • Summary Details
    OPEN
    Title: The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2008.06.018
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2008.02.011
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI
    Journal Name: Nature Protocols
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nprot.2017.081
    Citation Count: 143
  • Summary Details
    OPEN
    Title: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
    Journal Name: Archives of Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/archneurol.2011.53
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese Levels
    Journal Name: Archives of Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/archneurol.2011.771
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0038-3
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9
    Citation Count: 40
  • Summary Details
    OPEN
    Title: RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07780.x
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.